-
1
المؤلفون: Müller, LME, Holmes, M, Michael, JL, Scott, GB, West, EJ, Scott, KJ, Parrish, C, Hall, K, Stäble, S, Jennings, VA, Cullen, M, McConnell, S, Langton, C, Tidswell, EL, Shafren, D, Samson, A, Harrington, KJ, Pandha, H, Ralph, C, Kelly, RJ, Cook, G, Melcher, AA, Errington-Mais, F
المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-16 (2019)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Adult, Aged, 80 and over, Male, Oncolytic Virotherapy, Innate immunity, Adaptive immunity, Oncolytic viruses, Dendritic Cells, Middle Aged, Intercellular Adhesion Molecule-1, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Immunity, Innate, Leukemia, Myeloid, Acute, Cell Line, Tumor, Humans, Plasmacytoid DC, Female, Coxsackievirus A21, Aged, Enterovirus, T-Lymphocytes, Cytotoxic, Research Article
وصف الملف: text; application/pdf
-
2دورية أكاديمية
المؤلفون: Holmes M; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Scott GB; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Heaton S; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Barr T; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Askar B; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Müller LME; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Jennings VA; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.; The Institute of Cancer Research, Division of Radiotherapy and Imaging, Chester Beatty Laboratories, London SW3 6JB, UK., Ralph C; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Burton C; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals, Beckett Street, Leeds LS9 7TF, UK., Melcher A; The Institute of Cancer Research, Division of Radiotherapy and Imaging, Chester Beatty Laboratories, London SW3 6JB, UK., Hillmen P; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK., Parrish C; St James's University Hospital, Leeds Teaching Hospital, Beckett Street, Leeds LS9 7TF, UK., Errington-Mais F; Leeds Institute of Medical Research, University of Leeds, Beckett Street, Leeds LS9 7TF, UK.
المصدر: Molecular therapy oncolytics [Mol Ther Oncolytics] 2023 Mar 24; Vol. 29, pp. 17-29. Date of Electronic Publication: 2023 Mar 24 (Print Publication: 2023).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE
-
3دورية أكاديمية
المؤلفون: Müller LME; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Migneco G; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Scott GB; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Down J; Sheffield Myeloma Research Team, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., King S; Sheffield Myeloma Research Team, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Askar B; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Jennings V; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK., Oyajobi B; Cancer Therapy and Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Scott K; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., West E; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Ralph C; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Samson A; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Ilett EJ; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Muthana M; Sheffield Myeloma Research Team, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Coffey M; Oncolytics Biotech Inc, Calgary, Alberta, Canada., Melcher A; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK., Parrish C; Department of Haematology, St James's University Hospital, Leeds, UK., Cook G; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Lawson M; Sheffield Myeloma Research Team, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Errington-Mais F; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK F.Errington@leeds.ac.uk.
المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Oncolytic Virotherapy*, Bone Marrow/*immunology , CD8-Positive T-Lymphocytes/*immunology , Killer Cells, Natural/*immunology , Multiple Myeloma/*therapy , Oncolytic Viruses/*immunology , Reoviridae/*immunology , Spleen/*immunology , Tumor Microenvironment/*immunology, Animals ; Bone Marrow/virology ; CD8-Positive T-Lymphocytes/virology ; Cell Line, Tumor ; Coculture Techniques ; Cytokines/immunology ; Cytotoxicity, Immunologic ; Female ; Humans ; Killer Cells, Natural/virology ; Male ; Mice, Inbred C57BL ; Multiple Myeloma/immunology ; Multiple Myeloma/virology ; Oncolytic Viruses/pathogenicity ; Reoviridae/pathogenicity ; Spleen/virology ; Tumor Escape ; Mice